Looking ahead to FY22E and beyond, Covid-19 has proven to be a bane to MCAS’s margins even as 1H21 revenue met c.50% of FY21E expectations of IDR12,620bn.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.